These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33009966)

  • 1. Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.
    Nasri E; Shoaei P; Vakili B; Mirhendi H; Sadeghi S; Hajiahmadi S; Sadeghi A; Vaezi A; Badali H; Fakhim H
    Mycopathologia; 2020 Dec; 185(6):1077-1084. PubMed ID: 33009966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
    Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P
    J Mycol Med; 2021 Jun; 31(2):101122. PubMed ID: 33621792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
    Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
    J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study.
    Rouzé A; Lemaitre E; Martin-Loeches I; Povoa P; Diaz E; Nyga R; Torres A; Metzelard M; Du Cheyron D; Lambiotte F; Tamion F; Labruyere M; Boulle Geronimi C; Luyt CE; Nyunga M; Pouly O; Thille AW; Megarbane B; Saade A; Magira E; Llitjos JF; Ioannidou I; Pierre A; Reignier J; Garot D; Kreitmann L; Baudel JL; Voiriot G; Plantefeve G; Morawiec E; Asfar P; Boyer A; Mekontso-Dessap A; Makris D; Vinsonneau C; Floch PE; Marois C; Ceccato A; Artigas A; Gaudet A; Nora D; Cornu M; Duhamel A; Labreuche J; Nseir S;
    Crit Care; 2022 Jan; 26(1):11. PubMed ID: 34983611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis in the ICU: tale of a broadening risk profile.
    Koulenti D; Papathanakos G; Blot S
    Curr Opin Crit Care; 2023 Oct; 29(5):463-469. PubMed ID: 37641513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of galactomannan diagnostic assay in rhino-orbito-cerebral mycosis in COVID-19 patients.
    Chatterjee K; Taneja J; Agarwal C; Sasidharan J; Das A; Pandey A
    Indian J Med Microbiol; 2024; 48():100557. PubMed ID: 38447858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Infection and Late Manifestation of Pulmonary Aspergillosis.
    Bhopalwala H; Mishra V; Do TV; Gudipati M; Ganti SS
    J Investig Med High Impact Case Rep; 2022; 10():23247096211063332. PubMed ID: 34984948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single-centre cohort study.
    Janssens E; Huygens S; Moors I; Delie A; Kerre T; Vande Weygaerde Y; Van Braeckel E; Boelens J; Morbée L; Schauwvlieghe A
    Mycoses; 2024 Mar; 67(3):e13715. PubMed ID: 38477367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Apr; ():. PubMed ID: 34565575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
    Vanderbeke L; Jacobs C; Feys S; Reséndiz-Sharpe A; Debaveye Y; Hermans G; Humblet-Baron S; Lagrou K; Meersseman P; Peetermans M; Seldeslachts L; Vanstapel A; Vande Velde G; Van Wijngaerden E; Wilmer A; Verbeken E; De Hertogh G; Wauters J
    Am J Respir Crit Care Med; 2023 Aug; 208(3):301-311. PubMed ID: 37311243
    [No Abstract]   [Full Text] [Related]  

  • 11. Point-of-care testing for viral-associated pulmonary aspergillosis.
    Aerts R; Autier B; Gornicec M; Prattes J; Lagrou K; Gangneux JP; Hoenigl M
    Expert Rev Mol Diagn; 2024 Mar; 24(3):231-243. PubMed ID: 37688631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU.
    Fekkar A; Lampros A; Mayaux J; Poignon C; Demeret S; Constantin JM; Marcelin AG; Monsel A; Luyt CE; Blaize M
    Am J Respir Crit Care Med; 2021 Feb; 203(3):307-317. PubMed ID: 33480831
    [No Abstract]   [Full Text] [Related]  

  • 13. Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.
    Shah MM; Hsiao EI; Kirsch CM; Gohil A; Narasimhan S; Stevens DA
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):147-152. PubMed ID: 29454654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward?
    Gerber V; Boehn L; Sabou M; Studer A; Ursenbach A; Hansmann Y; Herbrecht R; Lefebvre N; Letscher-Bru V; Danion F
    Infect Dis Now; 2024 Jun; 54(4):104918. PubMed ID: 38636842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Aspergillus spp. in respiratory samples of patients with COVID-19 in a Spanish Tertiary Care Hospital.
    Falces-Romero I; Ruiz-Bastián M; Díaz-Pollán B; Maseda E; García-Rodríguez J;
    Mycoses; 2020 Nov; 63(11):1144-1148. PubMed ID: 32749040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Aspergillosis associated with Covid-19: A word of caution.
    Gouzien L; Cocherie T; Eloy O; Legriel S; Bedos JP; Simon C; Marque-Juillet S; Ferré A; Bruneel F
    Infect Dis Now; 2021 Jun; 51(4):383-386. PubMed ID: 33490993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters.
    Almuqrin AM; Alotaibi BA; Aldali JA; Alshalani A; AlSudais H; Aldali HJ
    BMC Infect Dis; 2024 Jun; 24(1):576. PubMed ID: 38862891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort study.
    Lee WC; Chang CC; Ho MC; Lin CM; Leu SW; Lin CK; Fang YH; Huang SY; Lin YC; Chuang MC; Yang TM; Hung MS; Chou YL; Tsai YH; Hsieh MJ
    Pneumonia (Nathan); 2024 May; 16(1):10. PubMed ID: 38790032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort.
    Dellière S; Dudoignon E; Fodil S; Voicu S; Collet M; Oillic PA; Salmona M; Dépret F; Ghelfenstein-Ferreira T; Plaud B; Chousterman B; Bretagne S; Azoulay E; Mebazaa A; Megarbane B; Alanio A
    Clin Microbiol Infect; 2020 Dec; 27(5):790.e1-5. PubMed ID: 33316401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genomic evaluations of a persistent fatal SARS-CoV-2 infection in a goods syndrome patient: a case report.
    Tabarsi P; Maleki A; Abtahian Z; Khabbaz A; Fereydouni Z; Rezaie J; Tavakoli M; Sanati PY; Salehi-Vaziri M
    BMC Infect Dis; 2024 Feb; 24(1):216. PubMed ID: 38373941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.